Skip to main content

New Ideas in Allergen-Specific Immunotherapy

Buy Article:

$41.50 plus tax (Refund Policy)

Immunotherapy represents the only allergen-specific treatment of allergic diseases. The clinical efficacy has been documented in a number of studies involving both rhinitis and asthma patients, although because of the multifactorial pathophysiology including hyperresponsiveness, asthma may not respond as satisfactorily as rhinitis. Owing to the capacity to reduce the release of allergic mediators and thereby the allergic inflammation, immunotherapy has advantages over the non-specific drug treatment primarily interfering at the target level of mediators. The clinical efficacy may be improved and the risk of side effects reduced by the use of modified allergens or by immunological manipulation in parallel with allergen administration.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics

Document Type: Research Article

Publication date: 1990-07-01

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more